Comparison of racemic albuterol and levalbuterol for treatment of acute asthma

Journal of Pediatrics

Volumn 143, Issue 6, 2003, Pages 731-736

  Carl, John C ^b   Myers, Timothy R ^b   Kirchner, H Lester ^b   Kercsmar, Carolyn M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEVALBUTEROL; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CHILD HOSPITALIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EMERGENCY HEALTH SERVICE; FEMALE; HEADACHE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEBULIZATION; PRIORITY JOURNAL; RACEMIC MIXTURE; RANDOMIZED CONTROLLED TRIAL; RASH; VOMITING;

EID: 0344825868     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00493-1     Document Type: Article

References (29)

1. Penn RB, Frielle T, McCullough FR, Aberg G, Benovic J. Comparison of R-, S-, and RS-albuterol interaction with human β1-and β2-adrenergic receptors. Clin Rev Allergy Immunol 1996;14:37-45.
2. Mitra S, Ugur M, Ugur O, Goodman HM, McCullough JR, Yamaguchi H. (S)-albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C dependent mechanism in airway smooth muscle. Mol Pharmacol 1998;53:347-54.
3. Yamaguchi H, McCullough J. (S)-Albuterol exacerbates calcium responses to carbachol in airway smooth muscle cells. Clin Rev Allergy Immunol 1996;14:47-55.
4. Volchek GAW, Gleich GJ, Kita H. Pro-and anti-inflammatory effects of β-adrenergic agonists on eosinophil response to IL-5. J Allergy Clin Immunol 1998;101:S35.
5. Leff AR, Hernreiter A, Naclerio RM, Baroody FM, Handley DA, Munoz NM. Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils. Pulm Pharmacol Ther 1997;10:97-104.
6. Dhand R, Goode M, Reid R, Fink JB, Fahey PJ, Tobin MJ. Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol. Am J Respir Crit Care Med 1999;160:1136-41.
7. Perrrin-Fayolle M, Blum P, Morley J, Grosclaude M, Chambe M. Differential responses of asthmatic airways to enantiomers of albuterol. Clin Rev Allergy Immunol 1996;14:139-47.
8. Cockcroft DW, Swystun VA. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol and placebo on the airway response to methacholine. Thorax 1997;53:845-8.
9. Page CP, Morley J. Contrasting properties of albuterol stereoisomers. J Allergy Clin Immunol 1999;104:S31-41.
10. Smeenk FW, Creemers JP, van den Borne BE, de Groot J, Ventresca GP, Ward JK. Effect of R-, S-and RE-albuterol on bronchial hyperresponsiveness (BHR) in asthmatics - no detrimental effect of S-albuterol. [abstract]. Am J Respir Crit Care Med 2000;1161:191.
11. Gumbir-Shar K, Kellerman DJ, DeGraw S, Koch P, Jusko WJ. Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol and enantiomers in asthmatic subjects. Pulm Pharmacol Ther 1999;12:353-62.
12. Lotvall J, Palmqvist M, Arvidsson P, Maloney A, Ventresca P, Ward J. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin Immunol 2001;108: 726-31.
13. Gawchik SM, Saccar CL, Noonan M, Reasner DS, DeGraw SS. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. J Allergy Clin Immunol 1999;103:615-21.
14. Milgrom H, Skoner CP, Bensch G, Kim KT, Claus R, Baumgartner RA. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol 2001;108:938-45.
15. Expert Panel Report 2. Guidelines for the diagnosis and management of asthma. 1997;NIH Pub. No. 97-4051, Bethesda, Maryland.
16. McDowell KM, Chatburn RL, Myers TR, O'Riordan MA, Kercsmar CM. A cost-saving algorithm for children hospitalized for status asthmaticus. Arch Pediatr Adolesc Med 1998;152:977-84.
17. Myers TR, Chatburn RL, Kercsmar CM. A pediatric asthma unit staffed by respiratory therapists demonstrates positive clinical and financial outcomes. Respir Care 1998;43:22-9.
18. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
19. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
20. Jung SH, Kang SH. Tests for 2xK contingency tables with clustered ordered categorical data. Stat Med 2001;20:785-94.
21. Cockcroft DW, Davis BE, Swystun VA, Marciniuk DD. Tolerance to the bronchoptotective effect of β2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo. J Allergy Clin Immunol 1999;103:1049-53.
22. Baramki D, Koester J, Anderson AJ. Modulation of T-cell function by (R)-and (S)-isomers of albutetol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J Allergy Clin Immunol 2002;109:449-54.
23. Jafarian A, Handley DA, Biggs DF. Effects of RS-albuterol on the development of antigen-mediated airway reactivity in guinea pigs. Clin Rev Allergy Immunol 1996;14:91-100.
24. Cockcroft DW, O'Byrne PM, Swystun VA, Bhagat R. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J Allergy Clin Immunol 1995;96:44-9.
25. Mazzoni L, Naef R, Chapman ID, Morley J. Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of β-selective sympathomimetics. Pulm Pharmacol 1994;7: 367-76.
26. Chetham P, Guldemeester H, Mons N, Brough G, Bridges J, Thompson W, et al. Calcium-inhibitable adenylyl cyclase and pulmonary microvascular permeability. Am J Physiol 1997;273:L22-30.
27. Nelson HS, Bensch G, Pleskow WW, DiSantostefano R, DeGraw S, Reasner DS, et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998; 102:943-52.
28. Craven D, Kercsmar CM, Myers TR, O'Riordan MA, Golonka G, Moore S. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. J Pediatr 2001;138:51-8.
29. Goggin N, Macarthur C, Parkin PC. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Arch Pediatr Adolesc Med 2001;155:1329-34.